The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU ASCO 2019 Non Hodgkin Lymphoma Update : Polatuzumab Vedotin for R/R DLBCL, Chemo for Waldenstroms, Lenalidomide and Rituximab in Relapsed Indolent Lymphoma, & Induction Rituximab in iNHL

450 views
August 19, 2019
0 Comments
Login to view comments. Click here to Login
Hematologic Malignancies